文献速递脊柱脊髓外科神经肿瘤

脊髓髓内与终丝肿瘤的长期结局:单中心病例系列

Intramedullary spinal cord and filum tumours-long-term outcome: single institution case series.
PubMed 文献 · Acta Neurochir (Wien) · 2022-09-27

该回顾性描述性研究报告52例脊髓髓内或终丝肿瘤长期存活者的长期神经功能结局、生活质量、生存、额外治疗需求及神经病理性疼痛频率;88%获得良好神经功能结局,大型头尾侧肿瘤及组织学证实的星形细胞瘤为严重残疾的负性预后因素,末次随访时54%存在神经病理性疼痛。

要点

  • 88%患者获得良好神经功能结局(ASIA D或E级,改良McCormick 1或2级)。
  • 大型头尾侧肿瘤(p=0.004)和组织学证实的星形细胞瘤(p=0.002)为严重残疾的负性预后因素。
  • 末次随访时54%患者存在神经病理性疼痛。

核心结论

  • 该系列显示,即使没有围手术期神经生理监测,髓内肿瘤手术也可获得良好结果。
  • 需要多中心研究进一步评估负性和正性预后因素以进一步改善结局。

研究设计与样本

  • 回顾性描述性研究,纳入52例同意参与研究的脊髓髓内或终丝肿瘤长期存活者。
  • 48例患者共接受56次手术。
  • 临床和影像学随访期分别为113个月和117个月。

主要发现

  • 88%获得良好神经功能结局(ASIA评分D或E级,改良McCormick分级1或2级)。
  • 严重残疾的负性预后因素为大型头尾侧肿瘤大小(p=0.004)和组织学证实的星形细胞瘤(p=0.002)。
  • SF-36显示身体功能全部五个子领域得分显著低于挪威常模,而心理健康和角色情感得分与挪威常模相比无显著差异。
  • 10例患者接受辅助治疗,包括所有星形细胞瘤患者、1例原始神经外胚层肿瘤和3例终丝终丝复发肿瘤;无髓内室管膜瘤患者接受辅助治疗。
  • 末次随访时54%患者存在神经病理性疼痛。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Intramedullary spinal cord tumours are rare and account for about 2-4% of primary CNS tumours. Ependymomas and astrocytomas are most frequent. The aim of this study was to evaluate the long-term neurological outcome, quality of life (QoL), survival, need for additional treatment and frequency of neuropathic pain in a patient group treated at a tertiary university hospital. METHOD: Retrospective descriptive study of 52 long-term survivors with intramedullary or filum tumours consenting to participate in this study. Fifty-six operations were performed in 48 patients. Clinical and radiological follow-up period was 113 and 117 months, respectively. RESULTS: Good neurological outcome (ASIA score D or E, modified McCormick grade 1 or 2) was achieved in 88%. We found two negative prognostic factors in regards of severe disability which were large craniocaudal tumour size (p = 0.004) and histologic verified astrocytomas (p = 0.002). SF-36 results showed significantly lower results on all five subdomains concerning physical function, whereas scores for mental health and role emotional showed no significant differences compared to Norwegian norms. Ten patients including all astrocytoma patients, one primitive neuroectodermal tumour and three recurrent tumours of filum terminale had adjuvant therapy. None of the patients with intramedullary ependymoma had adjuvant therapy. Neuropathic pain was present in 54% of patients at the last follow-up. CONCLUSION: This series shows that good results can be obtained with surgery for intramedullary tumours, even without perioperative neurophysiological monitoring. Multicentre studies are needed for further evaluation of negative and positive prognostic factors to further improve outcome.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Myrseth E, Habiba S, Rekand T, et al. Intramedullary spinal cord and filum tumours-long-term outcome: single institution case series. Acta Neurochir (Wien). 2022. PMID: 36166105. doi:10.1007/s00701-022-05350-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。